Novartis

Latest stories

4m
The Hindu
Gates Foundation on Centre’s radarThe Indian government will closely scrutinise the Bill & Melinda Gates Foundati
Gates Foundation on Centre’s radar
The Hindu / Posted 4 minutes ago
The Indian government will closely scrutinise the Bill & Melinda Gates Foundation’s (BMGF) methods of donations in India after an international report accused the world’s biggest philanthropist of influencing government policies in favour of... Read more
4h
PhysOrg
How Microsoft and Novartis created Kinect-based MS diagnostic toolMicrosoft researcher Cecily Morrison demonstrates Assess MS, a tool that aims t
How Microsoft and Novartis created Kinect-based MS diagnostic tool
PhysOrg / Posted 4 hours ago
Microsoft researcher Cecily Morrison demonstrates Assess MS, a tool that aims to bring more consistency to tracking the progress of multiple sclerosis symptoms. Credit: Jonathan Banks When Microsoft released the Kinect system for playing Xbox video... Read more
7h
Business Wire
Dr. Reddy’s Q3 and 9M FY16 Financial ResultsHYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY | B
Dr. Reddy’s Q3 and 9M FY16 Financial Results
Business Wire / Posted 7 hours ago
HYDERABAD, India--(BUSINESS WIRE)--Dr. Reddy’s Laboratories Ltd. (NYSE: RDY | BSE: 500124 | NSE: DRREDDY) today announced its consolidated financial results for the quarter ended December 31, 2015 under International Financial Reporting Standards... Read more
13 related stories
8h
Online Recruitment
SRG launches 2016 Salary Survey in conjunction with New ScientistBased on over 4,000 responses from SRG’s global database and the readership of
SRG launches 2016 Salary Survey in conjunction with New Scientist
Online Recruitment / Posted 8 hours ago
Based on over 4,000 responses from SRG’s global database and the readership of New Scientist magazine, the report provides the industry’s most comprehensive benchmarking tool for both employers and employees to assess salaries in relation to their... Read more
11h
Guardian Unlimited
In defence of pretentiousness | Dan FoxPretentiousness is always someone else’s crime. It’s never a felony in the firs
In defence of pretentiousness | Dan Fox
Guardian Unlimited / Posted 11 hours ago
Pretentiousness is always someone else’s crime. It’s never a felony in the first person. You might cop to the odd personality flaw; the occasional pirouette of self-deprecation is nothing if not good manners. Most likely one of those imperfections... Read more
18h
Channel NewsAsia
Novartis sets heart-drug price with two insurers based on health outcomeNEW YORK: U.S.-based health insurers Cigna Corp and Aetna Inc. have struck deal
Novartis sets heart-drug price with two insurers based on health outcome
Channel NewsAsia / Posted 18 hours ago
NEW YORK: U.S.-based health insurers Cigna Corp and Aetna Inc. have struck deals with Novartis AG for a performance-based price for the Swiss drugmaker's new heart drug, Entresto, the companies said on Monday. The agreements are among the few... Read more
19h
Business Insurance
Cigna enters outcomes-based pricing program with drugmakerHealth insurer Cigna Corp. and drugmaker Novartis A.G. have entered an outcomes
Cigna enters outcomes-based pricing program with drugmaker
Business Insurance / Posted 19 hours ago
Health insurer Cigna Corp. and drugmaker Novartis A.G. have entered an outcomes-based contract for Novartis' heart failure drug Entresto, Cigna announced Monday. Under the contract, Bloomfield, Connecticut-based Cigna will pay Basel,... Read more
20h
Business Wire
Model N Announces First Quarter of Fiscal Year 2016 Financial ResultsREDWOOD CITY, Calif.--(BUSINESS WIRE)--Model N, Inc., (NYSE:MODN), the leading
Model N Announces First Quarter of Fiscal Year 2016 Financial Results
Business Wire / Posted 20 hours ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Model N, Inc., (NYSE:MODN), the leading provider of cloud-based Revenue Management solutions to life science, technology and manufacturing companies, today announced financial results for the first quarter of... Read more
2 related stories
20h
Business Wire
Model N Founder Zack Rinat to Assume Role as Executive Chairman of the Board; Edward Sander to Assume Role as Chief Executive OfficerREDWOOD CITY, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leading
Model N Founder Zack Rinat to Assume Role as Executive Chairman of the Board; Edward Sander to Assume Role as Chief Executive Officer
Business Wire / Posted 20 hours ago
REDWOOD CITY, Calif.--(BUSINESS WIRE)--Model N, Inc. (NYSE: MODN), the leading provider of cloud-based Revenue Management solutions to life science, technology and manufacturing companies, today announced that effective February 21, 2016, Founder and... Read more
23h
San Antonio Express-News
Why Radius Health Inc. Dropped 45% in JanuaryWhat: Radius Health , a biopharmaceutical company focused on developing product
Why Radius Health Inc. Dropped 45% in January
San Antonio Express-News / Posted 23 hours ago
What: Radius Health , a biopharmaceutical company focused on developing products that treat osteoporosis and other endocrine-mediated diseases, had a rough January. The company's shares lost 45% of their value during the month, according to data from... Read more
1d
San Antonio Express-News
Can NewLink Genetics Win the Zika Vaccine Race?Image source: Wikimedia Commons. It seems the only thing spreading as fast as
Can NewLink Genetics Win the Zika Vaccine Race?
San Antonio Express-News / Posted yesterday
Image source: Wikimedia Commons. It seems the only thing spreading as fast as the Zika virus is the desire to develop a vaccine to prevent it. Recently, NewLink Genetics threw its hat into the ring along with GlaxoSmithKline , Sanofi , and Inovio... Read more
1d
San Antonio Express-News
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016Over the past few years, annual revenue growth of pharma giants Johnson & Johns
3 Potential Blockbusters Moving the Needle for Big Pharma in 2016
San Antonio Express-News / Posted yesterday
Over the past few years, annual revenue growth of pharma giants Johnson & Johnson , Novartis , and Bristol-Myers Squibb has been mostly flat to somewhat negative. Although each of these companies market dozens of products, making it hard for any one... Read more
1d
Business Standard India
Customs duty rise on life-saving drugs unlikely to affect patientsIndian companies are already producing these 15 drugs domesticallyIndian compan
Customs duty rise on life-saving drugs unlikely to affect patients
Business Standard India / Posted yesterday
Indian companies are already producing these 15 drugs domesticallyIndian companies are already producing these 15 drugs domestically Even as the government has imposed a customs duty... Read more
2d
Daily Telegraph
GSK investors split over break-up callsOther investors, however, are understood to be against a radical break-up of th
GSK investors split over break-up calls
Daily Telegraph / Posted 2 days ago
Other investors, however, are understood to be against a radical break-up of the company or the appointment of a new chief executive. One top 20 investor said: “This is a supertanker, Andrew Witty’s feet are fully to the fire and we should give the... Read more
2d
The Hindu
Zika virus outbreak: When research goes off the railsBrazil’s unwillingness to share Zika virus samples and data with WHO collaborat
Zika virus outbreak: When research goes off the rails
The Hindu / Posted 2 days ago
Brazil’s unwillingness to share Zika virus samples and data with WHO collaborating centres could delay the development of rapid and reliable diagnostic tests, vaccines and therapies The World Health Organisation (WHO) may have designated the Zika... Read more
3d
San Antonio Express-News
Why Ophthotech Corporation Shares Tumbled 31% in JanuarySource: Flickr user Luis Gustavo Zamudio A. What: Despite kicking off new tria
Why Ophthotech Corporation Shares Tumbled 31% in January
San Antonio Express-News / Posted 3 days ago
Source: Flickr user Luis Gustavo Zamudio A. What: Despite kicking off new trials in dry age-related macular degeneration, shares in Ophthotech Corporation dropped 31% in January, according to S&P Capital IQ. So what: In January, Ophthotech... Read more
3d
Fortune
Dear Biopharma Bros, Stop Treating Women Like ‘Chattel’“We can’t believe it’s 2016 and we have to spend our time writing this letter.”
Dear Biopharma Bros, Stop Treating Women Like ‘Chattel’
Fortune / Posted 3 days ago
“We can’t believe it’s 2016 and we have to spend our time writing this letter.” So begins an open letter to the biopharmaceutical industry and its investors, written by Karen Bernstein, co-founder and chairman of industry news site BioCentury... Read more
4d
Daily Mail
The electric coating that turns contact lenses into TVs: Film could be used to beam shows to your eyes or track glucose levels Concep
The electric coating that turns contact lenses into TVs
Daily Mail / Posted 4 days ago
: Film could be used to beam shows to your eyes or track glucose levels Concept was developed by scientists at the University of South Australia They used conductive polymer on a hydrogel and... Read more
4d
Morningstar
Pfizer's Pipeline Productivity Is ImprovingIn the quarter, growth from vaccine Prevnar 13 and recently launched drugs help
Pfizer's Pipeline Productivity Is Improving
Morningstar / Posted 4 days ago
In the quarter, growth from vaccine Prevnar 13 and recently launched drugs helped offset generic competition, leading to 5% year-over-year operational growth (excluding the Hospira acquisition). While the organic growth rate is likely to slow in 2016... Read more
4d
The Nashua Telegraph
Student wins biotech awardNASHUA - Winning a chance to collaborate with doctors on innovative cancer rese
Student wins biotech award
The Nashua Telegraph / Posted 4 days ago
NASHUA - Winning a chance to collaborate with doctors on innovative cancer research, Justin Yeung of the Academy for Science and Design was one of 100 students nationwide to receive the Emperor Science Award from Genentech, a San Francisco-based... Read more
4d
San Antonio Express-News
4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter ResultsImage source: GlaxoSmithKline via Flickr. We're smack dab in the middle of ear
4 Can't-Miss Numbers From GlaxoSmithKline's Fourth-Quarter Results
San Antonio Express-News / Posted 4 days ago
Image source: GlaxoSmithKline via Flickr. We're smack dab in the middle of earnings season, which means it's time to grab that cup of coffee and dig right in. On Wednesday, U.K.-based pharmaceutical giant GlaxoSmithKline reported its fourth-quarter... Read more
4d
San Antonio Express-News
ImmunoGen, Inc.'s Earnings Play the Amortization BluesImmunoGen released earnings for its second fiscal quarter on Friday, but with t
ImmunoGen, Inc.'s Earnings Play the Amortization Blues
San Antonio Express-News / Posted 4 days ago
ImmunoGen released earnings for its second fiscal quarter on Friday, but with the lack of any meaningful revenue, it was the update on its pipeline investors should be most interested in. Don't freak out about ImmunoGen going from a profit to a... Read more
4d
Pacific Coast Business Times
Amgen revenues up 8 percent in 2015Despite increased competition from biosimilars and blockbuster mergers by its r
Amgen revenues up 8 percent in 2015
Pacific Coast Business Times / Posted 4 days ago
Despite increased competition from biosimilars and blockbuster mergers by its rivals, Amgen revenues rose 8 percent to $21.67 billion in 2015 from $20.06 billion in 2014. Thousand Oaks-based biotech giant Amgen released its fourth-quarter earnings... Read more
5d
National Post
Story | Business Wire News Releases | News | Financial PostKlick attracts leading healthcare marketing professionals with its consistent g
Story | Business Wire News Releases | News | Financial Post
National Post / Posted 5 days ago
Klick attracts leading healthcare marketing professionals with its consistent growth, unique industry approach, and commitment to the ‘relentless pursuit of awesome’ TORONTO--(BUSINESS WIRE)--Klick Health today put an end to industry rumors and... Read more
5d
FOX News
Pfizer meningitis vaccine wins FDA approvalPfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis B,
Pfizer meningitis vaccine wins FDA approval
FOX News / Posted 5 days ago
Pfizer Inc has won U.S. approval for its Trumenba vaccine against meningitis B, a potentially deadly bacterial disease that has recently caused outbreaks on college campuses, the U.S. Food and Drug Administration said on Wednesday. Trumenba,... Read more
5d
FOX News
Troy Aikman's health warning ahead of Super Bowl 50Pro Football Hall of Famer Troy Aikman is speaking out about his battle against
Troy Aikman's health warning ahead of Super Bowl 50
FOX News / Posted 5 days ago
Pro Football Hall of Famer Troy Aikman is speaking out about his battle against melanoma, the most severe form of skin cancer. In 1998 the former Dallas Cowboys quarterback noticed a dark spot on his back shoulder and went to see a dermatologist to... Read more
5d
San Antonio Express-News
3 Value Stocks Near 52-Week Lows Worth BuyingWhile many companies' shares are rising past their fair values now, others are
3 Value Stocks Near 52-Week Lows Worth Buying
San Antonio Express-News / Posted 5 days ago
While many companies' shares are rising past their fair values now, others are trading at potentially bargain prices. The difficulty with bargain shopping, though, is that you may be understandably hesitant to buy stocks wallowing at 52-week lows. In... Read more
5d
Online Recruitment
Alexander Mann Solutions officially opens seventh Global Client Service Centre located in Gdansk, Poland, further expanding international reachThe Gdansk GCSC, located in the heart of the Alchemia Business Centre, will pla
Alexander Mann Solutions officially opens seventh Global Client Service Centre located in Gdansk, Poland, further expanding international reach
Online Recruitment / Posted 5 days ago
The Gdansk GCSC, located in the heart of the Alchemia Business Centre, will play an integral role in Alexander Mann Solutions’ integrated service offerings supporting international clients including Rolls Royce, Citi, GE, Deloitte, and Novartis. The... Read more
5d
MedCity News
4 investors share insights on health tech from J.P. Morgan that will shape 2016It’s been a frenetic couple of weeks between Consumer Electronics Show and J.P.
4 investors share insights on health tech from J.P. Morgan that will shape 2016
MedCity News / Posted 5 days ago
It’s been a frenetic couple of weeks between Consumer Electronics Show and J.P. Morgan Healthcare conference so now it’s time to take a broader look at what investors took away from them. The latter conference has certainly evolved since its start as... Read more
5d
Arkansas Democrat-Gazette
Swiss Syngenta says yes to China's $43BSix months ago, Syngenta said no to a $47 billion takeover attempt from Monsant
Swiss Syngenta says yes to China's $43B
Arkansas Democrat-Gazette / Posted 5 days ago
Six months ago, Syngenta said no to a $47 billion takeover attempt from Monsanto, arguing it was too risky. But times have changed. Commodities prices have slumped, decreasing the chances of a big payday for Syngenta, one of the world's biggest... Read more
106 related stories
5d
The Age
Food needs drive record Chinese takeoverChinese companies have shown themselves willing to put up increasingly larger s
Food needs drive record Chinese takeover
The Age / Posted 5 days ago
Chinese companies have shown themselves willing to put up increasingly larger sums of money to acquire foreign agricultural counterparts -- and expertise. Photo: Bloomberg America's biggest pork producer and a major agricultural commodities trader... Read more
106 related stories
5d
Sydney Morning Herald
Food needs drive record Chinese takeoverChinese companies have shown themselves willing to put up increasingly larger s
Food needs drive record Chinese takeover
Sydney Morning Herald / Posted 5 days ago
Chinese companies have shown themselves willing to put up increasingly larger sums of money to acquire foreign agricultural counterparts -- and expertise. Photo: Bloomberg America's biggest pork producer and a major agricultural commodities trader... Read more
106 related stories
5d
Canberra Times
Food needs drive record Chinese takeoverChinese companies have shown themselves willing to put up increasingly larger s
Food needs drive record Chinese takeover
Canberra Times / Posted 5 days ago
Chinese companies have shown themselves willing to put up increasingly larger sums of money to acquire foreign agricultural counterparts -- and expertise. Photo: Bloomberg America's biggest pork producer and a major agricultural commodities trader... Read more
106 related stories
5d
Brisbane Times
Food needs drive record Chinese takeoverChinese companies have shown themselves willing to put up increasingly larger s
Food needs drive record Chinese takeover
Brisbane Times / Posted 5 days ago
Chinese companies have shown themselves willing to put up increasingly larger sums of money to acquire foreign agricultural counterparts -- and expertise. Photo: Bloomberg America's biggest pork producer and a major agricultural commodities trader... Read more
106 related stories
5d
The News & Observer
GSK Q4 earnings beat Wall Street expectations | News & Observer February 3, 2016 5:56 PM Fourth quarter and full-year re
GSK Q4 earnings beat Wall Street expectations
The News & Observer / Posted 5 days ago
| News & Observer February 3, 2016 5:56 PM Fourth quarter and full-year revenue increased Sales of its asthma treatment Advair rose 2% but are projected... Read more
5d
The Irish Times
GSK chief asks for three years for profit increaseGlaxoSmithKline chief executive Andrew Witty asked investors to give him three
GSK chief asks for three years for profit increase
The Irish Times / Posted 5 days ago
GlaxoSmithKline chief executive Andrew Witty asked investors to give him three years to improve profitability at the biggest UK pharmaceutical company’s consumer-health unit. The company, which created a joint venture with Novartis for... Read more
6d
Market Watch
Investor fears eased as Glaxo results solidLONDON-- GlaxoSmithKline PLC Wednesday posted fourth-quarter revenue and profit
Investor fears eased as Glaxo results solid
Market Watch / Posted 6 days ago
LONDON-- GlaxoSmithKline PLC Wednesday posted fourth-quarter revenue and profit in line with analyst expectations and reinforced guidance that earnings would grow strongly in 2016, sending its shares higher. Glaxo, based in the London suburb of... Read more
6d
Perth Now
GSK posts $A876m loss British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG4
GSK posts $A876m loss
Perth Now / Posted 6 days ago
British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG428 million ($A876 million) for the fourth quarter of 2015 - compared with a profit of over STG1 billion for the same period a year earlier - as the... Read more
4 related stories
6d
Adelaide Now
GSK posts $A876m loss British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG4
GSK posts $A876m loss
Adelaide Now / Posted 6 days ago
British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG428 million ($A876 million) for the fourth quarter of 2015 - compared with a profit of over STG1 billion for the same period a year earlier - as the... Read more
4 related stories
6d
Herald Sun
GSK posts $A876m loss British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG4
GSK posts $A876m loss
Herald Sun / Posted 6 days ago
British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG428 million ($A876 million) for the fourth quarter of 2015 - compared with a profit of over STG1 billion for the same period a year earlier - as the... Read more
4 related stories
6d
Weekly Times
GSK posts $A876m loss British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG4
GSK posts $A876m loss
Weekly Times / Posted 6 days ago
British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG428 million ($A876 million) for the fourth quarter of 2015 - compared with a profit of over STG1 billion for the same period a year earlier - as the... Read more
4 related stories
6d
The Courier Mail
GSK posts $A876m loss British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG4
GSK posts $A876m loss
The Courier Mail / Posted 6 days ago
British-based pharmaceuticals giant GlaxoSmithKline has posted a loss of STG428 million ($A876 million) for the fourth quarter of 2015 - compared with a profit of over STG1 billion for the same period a year earlier - as the... Read more
4 related stories
6d
The Champaign News-Gazette
McCarter has to make $52,000 in campaign donation refundsCongressional fundraising in a nutshell: veteran U.S. Rep. John Shimkus of Coll
McCarter has to make $52,000 in campaign donation refunds
The Champaign News-Gazette / Posted 6 days ago
Congressional fundraising in a nutshell: veteran U.S. Rep. John Shimkus of Collinsville has a lot of it and his Republican challenger, Kyle McCarter, needs to refund more than half of his because of sloppy bookkeeping. Fourth quarter fundraising... Read more
6d
Hospitality Net
ARCHER® Hotel Under Development at The Green at Florham ParkSophisticated Boutique Hotel to Debut in Upscale New York Suburb FLORHAM PARK,
ARCHER® Hotel Under Development at The Green at Florham Park
Hospitality Net / Posted 6 days ago
Sophisticated Boutique Hotel to Debut in Upscale New York Suburb FLORHAM PARK, N.J. -- The Rockefeller Group, in collaboration with LodgeWorks Partners, L.P., will develop one of the only... Read more
6d
Business Standard India
Weak oil prices drag markets; Nifty ends below 7,400Financials were the top losers while oil shares also declined amid weak crude o
Weak oil prices drag markets; Nifty ends below 7,400
Business Standard India / Posted 6 days ago
Financials were the top losers while oil shares also declined amid weak crude oil pricesFinancials were the top losers while oil shares also declined amid weak crude oil prices Benchmark share... Read more
36 related stories
6d
Swissinfo
From Tea-Kettle Washer to China’s Biggest Dealmaker: Timeline(Bloomberg) -- State-backed China National Chemical Corp., commonly known as Ch
From Tea-Kettle Washer to China’s Biggest Dealmaker: Timeline
Swissinfo / Posted 6 days ago
(Bloomberg) -- State-backed China National Chemical Corp., commonly known as ChemChina, agreed to buy Swiss pesticide-and- seeds-maker Syngenta AG for more than $43 billion in the biggest acquisition by a Chinese company. Below is a timeline of... Read more
106 related stories
6d
Business Wire
Celyad annonce la nomination du Dr. Richard Mountfield au poste de Vice-Président, Global Regulatory AffairsCelyad (Paris:CYAD) (Brussels:CYAD) (Euronext Bruxelles et Paris, et NASDAQ : C
Celyad annonce la nomination du Dr. Richard Mountfield au poste de Vice-Président, Global Regulatory Affairs
Business Wire / Posted 6 days ago
Celyad (Paris:CYAD) (Brussels:CYAD) (Euronext Bruxelles et Paris, et NASDAQ : CYAD), leader dans la découverte et le développement de thérapies cellulaires spécialisées, avec des programmes cliniques portant sur les maladies cardiovasculaires et... Read more
454 related stories
6d
The Scientist
In Situ AntibodiesMB66 is a quick-dissolving film that carries antiviral human monoclonal antibod
In Situ Antibodies
The Scientist / Posted 6 days ago
MB66 is a quick-dissolving film that carries antiviral human monoclonal antibodies—grown in plants—to the mucosal surface of the vagina. In preclinical tests, the film has worked to block viral transmission for periods of 12 to 24 hours. In an... Read more
6d
Business Standard India
Sun Pharma, Lupin launch generics in USProduct launches will give boost to US businesses of two companiesProduct launc
Sun Pharma, Lupin launch generics in US
Business Standard India / Posted 6 days ago
Product launches will give boost to US businesses of two companiesProduct launches will give boost to US businesses of two companies Sun Pharmaceuticals and Lupin have launched the generic versions of top... Read more
7d
CIO
Google admits most 'moonshots' lose moneyGoogle's newly formed parent company, Alphabet, this week announced that its "m
Google admits most 'moonshots' lose money
CIO / Posted 7 days ago
Google's newly formed parent company, Alphabet, this week announced that its "moonshots," or big-bet investments such as self-driving cars, represent less than 1 percent of the organization's total 2015 revenue. Alphabet's "other bets" also decreased... Read more
167 related stories
More

People in this news